| 1. |
1. Guengerich, F. P., Kim, D. H., and Iwasaki, M. (1990) Role of human cytochrome P450 IIE1 in the oxidation of many low molecular
weight cancer suspects. Chem. Res. Toxicol. 14, 168–179.
|
| |
| 2. |
2. Yang, C. S., Yoo, J. S.H., Ishizaki, H., and Hong, J. (1990) Cytochrome P450 IIE1: roles in nitrosamine metabolism and
mechanism of regulation. Drug Metab. Rev. 22, 147–159.
|
| |
| 3. |
3. Koop, D. R. (1992) Oxidative and reductive metabolism by cytochrome P4502E1. FASEB J. 6, 724–730.
|
| |
| 4. |
4. Esktrom, G., and Ingelman-Sundberg, M. (1989) Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation
dependent on ethanol-inducible cytochrome P450. Biochem. Pharmacol. 38, 1313–1319.
|
| |
| 5. |
5. Tsukamoto, H., and Lu, S. C. (2001) Current concepts in the pathogenesis of alcoholic liver injury. FASEB J. 15, 1335–1349.
|
| |
| 6. |
6. Cederbaum, A. I. (2001) Introduction: serial review: alcohol, oxidative stress and cell injury. Free Rad. Biol. Med. 31, 1524–1526.
|
| |
| 7. |
7. Castillo, T., Koop, D. R., Kamimura, S., Triadafilopoulos, G., and Tsukamoto, H. (1992) Role of cytochrome P4502E1 in ethanol-,
carbon tetrachloride-, and iron-dependent microsomal lipid peroxidation. Hepatology
16, 992–996.
|
| |
| 8. |
8. Morimoto, M., Zern, M. A., Hagbjork, A. L., Ingelman-Sundberg, M., and French, S. W. (1994) Fish oil, alcohol, and liver
pathology: role of cytochrome P4502E1. Proc. Soc. Exp. Biol. Med. 207, 197–205.
|
| |
| 9. |
9. Nanji, A. A., Zhao, S., Sadrzadeh, S. M.H., Dannenberg, A. J., Tahan, S. T., and Waxman, D. J. (1994) Markedly enhanced
cytochrome P4502E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-ethanol-fed rats. Alcohol. Clin. Exp. Res. 18, 1280–1285.
|
| |
| 10. |
10. Gouillon, Z., Lucas, D., Li, J., Hagbjork, A. L., French, B. A., Fu, P., Fang, C., Ingelman-Sundberg, M., Donohue, T.
M. Jr., and French, S. W. (2000) Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole.
Proc. Soc. Exp. Biol. Med. 224; 302–308.
|
| |
| 11. |
11. Koop, D. R., Klopfenstein, B., Iimuro, Y., and Thurman, R. G. (1997) Gadolinium chloride blocks alcohol-dependent liver
toxicity in rats treated chronically with intragastric alcohol despite the induction of CYP2E1. Mol. Pharmacol. 51, 944–950.
|
| |
| 12. |
12. Kono, H., Bradford, B. U., Yin, M., Sulik, K. K., Koop, D. R., Peters, J. M., Gonzalez, F. J., McDonald, T., Dikalova,
A., Kadiiska, M. B., et al. (1999) CYP2E1 is not involved in early alcohol-induced liver injury. Am. J. Physiol. 277, G1259-G1267.
|
| |
| 13. |
13. Isayama, F., Froh, M., Bradford, B. U. Mckim, S. E., Kadiiska, M. B., Connor, H. D., Mason, R. P., Koop, D. R., Wheeler,
M. D., and Arteel, G. E. (2003) The CYP inhibitor 1-aminobenzotriazole does not prevent oxidative stress associated with alcohol-induced
liver injury in rats and mice. Free Rad. Biol. Med. 35, 1568–1581.
|
| |
| 14. |
14. Morgan, K., French, S. W., and Morgan, T. R. (2002) Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation
of alcoholic liver damage. Hepatology. 36, 122–134.
|
| |
| 15. |
15. Bardag-Gorce, F., Yuan, Q. X., Li, J., French, B. A., Fang, C., Ingelman-Sundberg, M., and French, S. W. (2000) The effect
of ethanol-induced cytochrome P450 2E1 on the inhibition of proteasome activity by alcohol. Biochem. Biophys. Res. Commun. 279, 23–29.
|
| |
| 16. |
16. Bradford, B. U., Kono, H., Isayama, F., Kosyk, O. Wheeler, M. D., Akiyama, T. E., et al (2005) Cytochrome P4502E1 but
not NADPH oxidase is required for ethanol-induced oxidative DNA damage in rodent liver. Hepatology
41, 336–344.
|
| |
| 17. |
17. Tanaka, E., Terada, M., and Misawa, S. (2000) Cytochrome P450 2E1: its clinical and toxicological role. J. Clin. Pharm. Ther. 25, 165–175.
|
| |
| 18. |
18. Gonzalez, F. J. (2005) Role of cytochromes P450 in chemical toxicology and oxidative stress I studies with CYP2E1. Mutat. Res. 569, 101–110.
|
| |
| 19. |
19. Dai, Y., Rashba-Step, J., and Cederbaum, A. I. (1993) Stable transfection of human cytochrome P4502E1 in HepG2 cells:
characterization of catalytic activities and production of reactive oxygen intermediates. Biochemistry
32, 6928–6937.
|
| |
| 20. |
20. Chen, Q., and Cederbaum, A. I. (1998) Cytotoxicity and apoptosis produced by cytochrome P450 2E1 in HepG2 cells. Mol. Pharmacol. 53, 638–648.
|
| |
| 21. |
21. Dai, Y., and Cederbaum, A. I. (1995) Cytotoxicity of acetaminophen in human cytochrome P4502E1-transfected HepG2 cells.
J. Pharmacol. Exp. Ther. 273, 1497–1505.
|
| |
| 22. |
22. Dai, Y., and Cederbaum, A. I. (1995) Inactivation and degradation of human cytochrome P4502E1 by CCl4 in a transfected
HepG2 cell line. J. Pharmacol. Exp. Ther. 275, 1614–1622.
|
| |
| 23. |
23. Wu, D., and Cederbaum, A. I. (1996) Ethanol toxicity to transfected HepG2 cells expressing human cytochrome P4502E1. J. Biol. Chem. 271, 23914–23919.
|
| |
| 24. |
24. Chen, Q., Galleano, M., and Cederbaum, A. I. (1997) Cytotoxicity and apoptosis produced by arachidonic acid in HepG2 cells
overexpressing human cytochrome P4502E1. J. Biol. Chem. 272, 14532–14541.
|
| |
| 25. |
25. Wu, D., and Cederbaum, A. I. (1999) Ethanol-induced apoptosis to hepatic cell lines expressing human cytochrome P4502E1.
Alcohol. Clin. Exp. Res. 23, 67–76.
|
| |
| 26. |
26. Sakurai, K., and Cederbaum, A. I. (1998) Oxidative stress and cytotoxicity induced by ferric-nitrilotriacetate in HepG2
cells expressing CYP2E1. Mol. Pharmacol. 54, 1024–1035.
|
| |
| 27. |
27. Wu, D., and Cederbaum, A. I. (2001) Removal of glutathione produces apoptosis and necrosis in HepG2 cells overexpressing
CYP2E1. Alcohol. Clin. Exp. Res. 25, 619–628.
|
| |
| 28. |
28. Caro, A. A., and Cederbaum, A. I. (2004) Oxidative stress, toxicology and Pharmacology of CYP2E1. Annu. Rev. Pharmacol. Toxicol. 44, 27–42.
|
| |
| 29. |
29. Kessova, I. and Cederbaum, A. I. (2003) CYP2E1: Biochemistry, toxicology and regulation. Curr. Mol. Med. 3, 509–518.
|
| |
| 30. |
30. Jimenez-Lopez, J. M., and Cederbaum, A. I. (2005) CYP2E1-dependent oxidative stress and toxicity: role in ethanol-induced
liver injury. Expert Opinion Drug Metab. Toxicol. 1, 671–685.
|
| |